14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
LABU vs TECL: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
LABU Captures Overall Composite Edge (49.4 HOLD vs 52.1 HOLD), While TECL Leads 1–0 on Growth & Valuation Pillars
LABU Overall Winner
6-Pillar Tally: LABU 0 – 1 TECL (5 Tie)
Matrix Metrics: LABU 2 – 1 TECL
As of Nov 16, 2026, Direxion Daily S&P Biotech Bull 3X Shares (LABU) captures the overall head-to-head institutional edge over Direxion Daily Technology Bull 3x Shares (TECL) on higher Unified Composite conviction (49.4/100 HOLD vs. 52.1/100 HOLD) after splitting the core matrix 2–1 (led by composite factor balance), while TECL wins 1–0 across the 6-pillar growth and valuation breakdown. LABU trades at $195.22 (N/M Forward P/E, N/A operating margin) versus TECL at $127.76 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While TECL currently prints a higher short-term Unified Composite Score (52.1/100 HOLD vs. LABU 49.4/100 HOLD), LABU captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–1 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
Technical & Structure Timing Caution: LABU is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.4); meanwhile TECL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 33.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on LABU vs TECL. Trailing 12-month operating profitability (LABU N/A vs TECL N/A) and valuation multiples (LABU N/M vs TECL N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ LABU vs TECL Key Questions & Quantitative Answers
As of Nov 16, 2026, Direxion Daily S&P Biotech Bull 3X Shares (LABU) captures the overall head-to-head institutional edge over Direxion Daily Technology Bull 3x Shares (TECL) on higher Unified Composite conviction (49.4/100 HOLD vs. 52.1/100 HOLD) after splitting the core matrix 2–1 (led by composite factor balance), while TECL wins 1–0 across the 6-pillar growth and valuation breakdown. LABU trades at $195.22 (N/M Forward P/E, N/A operating margin) versus TECL at $127.76 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While TECL currently prints a higher short-term Unified Composite Score (52.1/100 HOLD vs. LABU 49.4/100 HOLD), LABU captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–1 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY). Technical & Structure Timing Caution: LABU is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.4); meanwhile TECL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 33.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
LABU and TECL split Growth & Scale metrics: LABU posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with TECL at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, LABU generates N/A in USD-normalized revenue versus N/A for TECL. In operating R&D and SG&A reinvestment, LABU deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for TECL.
LABU and TECL trade at balanced relative valuation multiples. LABU trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas TECL trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against LABU (N/A ROE) versus TECL (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, LABU carries 86.4% implied volatility (12th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (3.71β · 119% Vol realized risk). By comparison, TECL carries 92.4% implied volatility (6th %ile, Compressed (<25th %ile)), a 1.02x (Balanced) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (5.46β · 133% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.